LQR House (NasdaqGM: LQR) shares soared by 40% after making their NasdaqGM debut. The rally led to LQR shares reaching $7.01 before giving back gains in the afternoon session. The bullish reception did send a strong message, however: investors are on-board and willing to pay higher prices to join LQR’s mission of providing a 21st-century […]
Successful IPO to NYSE-Amer market raises over $6 million to fuel expanding treatment reach of IB-Stim technology NeurAxis (NYSE-Amer: NRXS) scored a significant milestone on Wednesday, making its NYSE-American market debut, selling 1,098,667 common shares and raising roughly $6.59 million before underwriting discounts and commissions. The capital raise may not end there. The company also […]
LQR House (NASDAQ: LQR) is changing the face of the spirits sector, replacing the old tired one with a look that is fresh, updated, and in the 21st-century sales model- Digital. But don’t think of LQR as another one of those boring subscription clubs. LQR is doing something different. And by leveraging its mastery of […]
Stocks retreated Tuesday as an August sell-off was reignited by a downgrade of the banking sector by credit rating agency Moody’s. The Dow Jones Industrial Average was down 151 points, or 0.4%, led by a decline in Goldman Sachs. The S&P 500 dipped 0.5%, bringing the broad index’s month-to-date loss to 2%. The Nasdaq Composite […]
LZG International (OTC: LZGI), also known as FatBrain AI, is an under-the-radar AI sector investment opportunity not to be ignored. That’s no exaggeration of fact. Quite the contrary, noting that this roughly $0.90 stock and the company behind it are already positioned as leaders in providing powerful and easy-to-use AI solutions for the enterprise stars […]
The S&P 500 fell to start August, as investors navigated a flood of corporate earnings reports and assessed a fresh batch of economic data. The broad-based index lost 0.2%, while the Nasdaq Composite edged 0.3% lower. The Dow Jones Industrial Average added 75 points, or 0.2%. On a down day, MANGOCEUTICALS, INC. (MGRX) was up […]
Artificial intelligence has been part of our technological landscape for quite a while, but it became even more prominent with the advent of ChatGPT and several similar applications towards the end of 2022. These innovative tools had the ability to draft reports, sift through complex data, and enhance efficiency across numerous tasks. This sparked a […]
Amidst the summer’s heat and cherished family moments, the stock market keeps its pace, offering opportunities for watchful traders. Many traders like the action behind stocks trading under $0.02, as they can become magnets for those seeking profitable momentum plays and dip buying strategies. Amidst the summer’s heat and cherished family moments, the stock market […]
Cybersecurity used to be a word people heard but seldom reacted to. And that disregard may have been acceptable several years ago. But not anymore. The sophistication of cybercrime, which attacks individuals and billion-dollar companies, and everyone in between, should not be taken lightly. In fact, in no uncertain terms, an immediate call to action […]
Dr. Reddy’s Laboratories (NSE: DRREDDY), an internationally renowned pharmaceutical corporation with its main operations in India, announced on June 23 that it’s expanding into the Indian trade generics industry by unveiling a novel business unit, RGenX. Initially, the company’s trade generics line will target products intended for acute care. The business model, relying heavily on […]
